Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer
Post-NAC plasma tumor fraction and change in tumor-derived methylation signal predict the extent of RD and recurrence in TNBC patients.
Authors
- Julia Foldi (ORCID: https://orcid.org/0000-0002-7504-867X)
- Lajos Pusztai (ORCID: https://orcid.org/0000-0001-9632-6686)
- Pan Du (ORCID: https://orcid.org/0000-0002-1124-8963)
- Kim Blenman (ORCID: https://orcid.org/0000-0001-6070-0728)
- Billie Gould (ORCID: https://orcid.org/0000-0001-8603-8007)
- Giancarlo Bonora (ORCID: https://orcid.org/0000-0001-7558-3798)
- Naing Lin Shan (ORCID: https://orcid.org/0000-0002-8572-1311)
- Xiaohong Wang (ORCID: https://orcid.org/0000-0001-8628-243X)
- Gerson Espinoza Campos
- Myles Walsh
Institutions
- Yale Cancer Center (US)
- Yale University (US)
Publication Details
- Journal
- The Journal of Liquid Biopsy
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.jlb.2024.100168
- Citations
- 12
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 3.42
Funders
- Breast Cancer Research Foundation